"RETROSPECTIVE STUDY ABOUT "PRECISION SURGICAL MANAGEMENT OF ACRAL LENTIGINOUS MELANOMA"

Abstract

Background: Acral Lentiginous Melanoma (ALM), a rare but aggressive form of cutaneous melanoma, affects about 2-3% of melanoma patients in Western populations. It primarily targets acral areas like palms, soles, and subungual regions, and is more common in individuals with darker skin tones. ALM’s unique biological and molecular properties, coupled with delayed diagnosis and lack of awareness, contribute to its aggressive nature and poorer prognosis compared to other melanoma types. Our goal was to explore the surgical management of ALM by analyzing patient demographics, tumor locations, and surgical outcomes.

Methods: We conducted a retrospective study on 50 ALM patients treated at the 1st Affiliated Hospital of Xinjiang Medical University from September 2017 to January 2022.

Results: The study's primary surgical method, wide local excision proved highly effective with no local recurrence in 50 treated cases, emphasizing its significance in managing Acral Lentiginous Melanoma (ALM). Tumor analysis revealed a predominant occurrence (66%) in acral areas, particularly the sole (36%) and heel (30%), emphasizing the need for precise surgical interventions in these locations. Demographically, ALM primarily affected individuals aged 41 to 70 (72% of cases), with a slight female preponderance (31 females, 19 males). Most cases were in the Chinese population (78%), providing comprehensive insights into the diverse patient characteristics associated with ALM. Top of Form

Conclusion: This study enhances our knowledge of ALM management by highlighting the significance of precision medicine and customized surgical strategies for improved patient outcomes. By focusing on the surgical aspects of ALM management, we aim to optimize oncological results and enhance patient well-being.